-
PM launches global e-library, which puts traditional meds on world map
20 Dec 2025 09:13 GMT
… diseases such as diabetes, heart disease, depression and cancer. "Restoring … with modern treatment, and highlighted ongoing clinical studies on anaemia, arthritis and … Contribution to the Promotion and Development of Yoga, recognising their sustained …
-
Trump secures agreements with Merck, Amgen, Novartis and others to cut drug prices under Medicaid
20 Dec 2025 02:21 GMT
… savings” on widely used drugs, though they did not … will sell its diabetes drugs Januvia, Janumet and … to include migraine drug Aimovig and arthritis treatment Amjevita, pricing both … billion in US research, development and manufacturing, though officials …
-
White House announces more deals to bring down prescription drug prices
20 Dec 2025 02:14 GMT
… cancer, diabetes, heart disease, a slew of problems … agreements impact drugs used for treatment for diabetes, rheumatoid arthritis, multiple … to $100 for diabetes medication Januvia from Merck through … mission to to discover, develop and deliver life saving …
-
Trump, 9 drug companies strike deal to cut prescription prices
20 Dec 2025 00:58 GMT
… more than in other developed nations, and Trump has … drugs expected to receive a speedy review under the FDA’ … it will add migraine drug Aimovig and arthritis treatment Amjevita to its … about 70% on treatments for infections, heart disease, and diabetes.
…
-
Nine drugmakers cut deal with Trump administration to slash medication costs
19 Dec 2025 23:27 GMT
… drugs for Medicaid recipients and people who buy the medications … disease, hepatitis B and C, HIV, multiple sclerosis, rheumatoid arthritis … families from continued abusive drug pricing practices.”
Before … Trump administration to lower drug prices.
Trump said …
-
FNIH Announces FDA Qualification of First Surrogate Endpoint for Use in Osteoporosis Clinical Trials
19 Dec 2025 23:19 GMT
… National Institute of Arthritis and Musculoskeletal and … drug development.
“Drugs for reducing fractures are available, but treatment … fracture due to the disease. The clinical, medical … KEYWORD: BIOTECHNOLOGY FDA HEALTH PHARMACEUTICAL CLINICAL TRIALS
SOURCE: …
-
<![CDATA[FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis]]>
19 Dec 2025 23:01 GMT
… release. “A progressive disease condition process like … eagerly awaiting additional treatment options. The FDA approval of … disorders like rheumatoid arthritis or systemic sclerosis— … clinical trial (NCT05321082), which compared nerandomilast treatment with …
-
Trump announces new deal with pharma companies to cut drug prices
19 Dec 2025 22:44 GMT
… on their medications to match that of the developed nation … -consumer prices of select drugs sold potentially through the … drugs expected to receive a speedy review under the FDA … to include migraine drug Aimovig and rheumatoid arthritis medicine Amjevita, …
-
Trump Strikes Deals with 9 More Companies to Drastically Lower Drug Prices for Americans
19 Dec 2025 22:40 GMT
… to happen on drug pricing and on health care.”
Drugs that treat … pulmonary disease, Hepatitis B and C, HIV, multiple sclerosis, rheumatoid arthritis, and … cost by 80 percent, rheumatoid arthritis medication Xeljanz will be cut nearly …
-
Trump announces lower drug prices in deals with nine companies
19 Dec 2025 22:30 GMT
… sheet.
Most people get drugs through Medicare, employers… rheumatoid arthritis, multiple sclerosis, asthma, chronic obstructive pulmonary disease, … pill once it is approved by the Food and Drug … medication Aimovig at a 60% reduction and autoimmune treatment …